ClearingBid, Inc.

02/24/2025

Our latest Five Questions for the Expert (5Q4E) from Benji T. Jones.

Among the most clear-thinking legal minds in the capital raise space, Benji walks us through the JOBS Act and deftly outlines the plusses and minuses of an IPO & Reg A+ offering.

Highlights include an overview of the JOBS Act which has made it easier for companies to raise capital through General Solicitation (Title II), Equity Crowdfunding (Title III) and Reg A+ (Title IV). Issuers can raise up to $75 million.

She also discusses why rising sophistication in the crowdfunding space means a Reg A+ can be a viable alternative to an IPO. She explains what makes a Reg A+ successful, gives examples & lays out the difference for investors & IR.

A problem as old as time: how to raise capital to fuel a growing business? Thanks to the JOBS Act and other innovations, there are more options than ever to make this happen.



https://www.clearingbid.com/5q4e/details/benji-jones

02/18/2025

How will the chaotic environment in D.C. impact the financial technology sector?

02/06/2025

Find out more about ClearingBid in this great interview with our CEO Matt Venturi from Superpowers for Good. Thanks to Devin Thorpe, Best Selling Author & CEO of The Super Crowd, Inc., a public benefit corporation for the time and opportunity to share our thoughts.

Excited to share tomorrow's episode of Superpowers for Good on e360tv OTT Network with Matt Venturi, Founder & CEO, ClearingBid, Inc.

To watch the episode, visit: https://s4g.biz/tv or download the channel app to your streaming device--Roku Inc., AppleTV or AmazonFireTV--or your mobile device. Hosted by Devin Thorpe the show streams at 11 a.m. Eastern/ 8 Pacific. Don't miss it!

02/04/2025

20/20 GeneSystems Inc, a market leader in multi-cancer early detection blood testing, has retained ClearingBid for its anticipated later this year. Find out more about this innovative company at https://2020gene.com as well as at the Wefunder campaign closing Feb 14.

20/20 GeneSystems We Modernize Clinical Lab Testing with Machine Learning and Real-World Data Learn More Our Products OneTest™ for Cancer OneTest is the fir ...

11/20/2024

🤣🤣🤣

11/19/2024

Welcome to the team Cara Pellicano!
https://www.clearingbid.com/news/details/cara-pellicano-hired

11/14/2024

Learn about the Engagement Agreement between ClearingBid, Inc. & 20/20 GeneSystems, Inc., an early market leader in multi-cancer early detection blood testing.

Join a call with ClearingBid CEO Matt Venturi & 20/20 CEO Jonathan Cohen on Nov 20, 2024 1:00PM
www.clearingbid.com

11/12/2024

20/20 GeneSystems Inc., an early market leader in multi-cancer early detection blood testing, announces that it has entered an Engagement Agreement with ClearingBid, Inc., a provider of the first platform enabling ordinary individuals and institutions to invest in IPOs at the same time, and on the same terms, as Wall Street’s largest investment firms.

20/20 was one of the first life science companies to succeed with equity crowdfunding, having raised over $12 million from more than 7,000 retail investors to date. The company is currently raising on Wefunder. Last month, ClearingBid received the “Rocket Launch Award” from the Crowdfunding Professional Association for having raised $5 million through its Reg CF offering in 2023 from nearly 4,000 investors on Wefunder, in just 39 days.

Ron Baker [email protected]

Full Release
https://2020gene.com/20-20-genesystems-enters-engagement-agreement-with-clearingbid-pioneer-of-the-first-crowd-powered-open-ipos/

10/23/2024

10/17/2024

Author Dakin Campbell updates us on his book, Going Public, written 2 years ago

- The IPO market collapse & meager recovery have stalled innovation

- Retail is still only 5-10% of the typical IPO – a missed opportunity for issuers, brokers and small investors

- He reviews the Google 20 years on.

Find our more at our website
https://www.clearingbid.com/5q4e/details/dakin-campbell-three

10/09/2024

Going to the Crowdfunding Professional Association Regulated Investment Crowdfunding Summit Oct 22-23? Meet our management team: Founder & CEO Matt Venturi and Head of Ops Kayle Watson. Our platform democratizes the & Reg A process, broadening access to investors & optimizing your capital raise.

09/19/2024

Our latest 5Q4E
Professor Edward Altman updates us about the credit cycle – some things are looking OK but there are some concerns as we look to 2025. Recovery rates have rebounded, interest rates are headed down but bankruptcies are way up and new issuance that needs to be floated to replace old debt could start to be problematic. Find our more at our website

https://www.clearingbid.com/5q4e/details/ed-altman-two

WiserFunds